COVID-19 Impact on Global Skin Disease Treatment Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Skin Disease Treatment Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Skin Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Medicated Creams and Ointments
  • 1.4.3 Antibiotics
  • 1.4.4 Vitamins and Steroids
  • 1.4.5 Antihistamines
  • 1.4.6 Laser Therapy
  • 1.4.7 Antifungals
  • 1.4.8 Others
• 1.5 Market by Application
  • 1.5.1 Global Skin Disease Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Dermatology Clinics
  • 1.5.3 Skincare Clinics
  • 1.5.4 Hospitals
  • 1.5.5 Aesthetic Centers
  • 1.5.6 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Skin Disease Treatment Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Skin Disease Treatment Industry
    • 1.6.1.1 Skin Disease Treatment Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Skin Disease Treatment Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Skin Disease Treatment Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Skin Disease Treatment Market Perspective (2015-2026)
• 2.2 Skin Disease Treatment Growth Trends by Regions
  • 2.2.1 Skin Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Skin Disease Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Skin Disease Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Skin Disease Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Skin Disease Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Skin Disease Treatment Players by Market Size
  • 3.1.1 Global Top Skin Disease Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Skin Disease Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Skin Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Skin Disease Treatment Market Concentration Ratio
  • 3.2.1 Global Skin Disease Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Skin Disease Treatment Revenue in 2019
• 3.3 Skin Disease Treatment Key Players Head office and Area Served
• 3.4 Key Players Skin Disease Treatment Product Solution and Service
• 3.5 Date of Enter into Skin Disease Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Skin Disease Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Skin Disease Treatment Forecasted Market Size by Type (2021-2026)

5 Skin Disease Treatment Breakdown Data by Application (2015-2026)

• 5.1 Global Skin Disease Treatment Market Size by Application (2015-2020)
• 5.2 Global Skin Disease Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Skin Disease Treatment Market Size (2015-2020)
• 6.2 Skin Disease Treatment Key Players in North America (2019-2020)
• 6.3 North America Skin Disease Treatment Market Size by Type (2015-2020)
• 6.4 North America Skin Disease Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Skin Disease Treatment Market Size (2015-2020)
• 7.2 Skin Disease Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Skin Disease Treatment Market Size by Type (2015-2020)
• 7.4 Europe Skin Disease Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Skin Disease Treatment Market Size (2015-2020)
• 8.2 Skin Disease Treatment Key Players in China (2019-2020)
• 8.3 China Skin Disease Treatment Market Size by Type (2015-2020)
• 8.4 China Skin Disease Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Skin Disease Treatment Market Size (2015-2020)
• 9.2 Skin Disease Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Skin Disease Treatment Market Size by Type (2015-2020)
• 9.4 Japan Skin Disease Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Skin Disease Treatment Market Size (2015-2020)
• 10.2 Skin Disease Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Skin Disease Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Skin Disease Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Skin Disease Treatment Market Size (2015-2020)
• 11.2 Skin Disease Treatment Key Players in India (2019-2020)
• 11.3 India Skin Disease Treatment Market Size by Type (2015-2020)
• 11.4 India Skin Disease Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Skin Disease Treatment Market Size (2015-2020)
• 12.2 Skin Disease Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Skin Disease Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Skin Disease Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 APEIRON Biologics AG
  • 13.1.1 APEIRON Biologics AG Company Details
  • 13.1.2 APEIRON Biologics AG Business Overview and Its Total Revenue
  • 13.1.3 APEIRON Biologics AG Skin Disease Treatment Introduction
  • 13.1.4 APEIRON Biologics AG Revenue in Skin Disease Treatment Business (2015-2020))
  • 13.1.5 APEIRON Biologics AG Recent Development
• 13.2 HanAll BioPharma
  • 13.2.1 HanAll BioPharma Company Details
  • 13.2.2 HanAll BioPharma Business Overview and Its Total Revenue
  • 13.2.3 HanAll BioPharma Skin Disease Treatment Introduction
  • 13.2.4 HanAll BioPharma Revenue in Skin Disease Treatment Business (2015-2020)
  • 13.2.5 HanAll BioPharma Recent Development
• 13.3 GlaxoSmithKline plc.
  • 13.3.1 GlaxoSmithKline plc. Company Details
  • 13.3.2 GlaxoSmithKline plc. Business Overview and Its Total Revenue
  • 13.3.3 GlaxoSmithKline plc. Skin Disease Treatment Introduction
  • 13.3.4 GlaxoSmithKline plc. Revenue in Skin Disease Treatment Business (2015-2020)
  • 13.3.5 GlaxoSmithKline plc. Recent Development
• 13.4 Allergen, Plc.
  • 13.4.1 Allergen, Plc. Company Details
  • 13.4.2 Allergen, Plc. Business Overview and Its Total Revenue
  • 13.4.3 Allergen, Plc. Skin Disease Treatment Introduction
  • 13.4.4 Allergen, Plc. Revenue in Skin Disease Treatment Business (2015-2020)
  • 13.4.5 Allergen, Plc. Recent Development
• 13.5 Anacor Pharmaceuticals
  • 13.5.1 Anacor Pharmaceuticals Company Details
  • 13.5.2 Anacor Pharmaceuticals Business Overview and Its Total Revenue
  • 13.5.3 Anacor Pharmaceuticals Skin Disease Treatment Introduction
  • 13.5.4 Anacor Pharmaceuticals Revenue in Skin Disease Treatment Business (2015-2020)
  • 13.5.5 Anacor Pharmaceuticals Recent Development
• 13.6 Celgene
  • 13.6.1 Celgene Company Details
  • 13.6.2 Celgene Business Overview and Its Total Revenue
  • 13.6.3 Celgene Skin Disease Treatment Introduction
  • 13.6.4 Celgene Revenue in Skin Disease Treatment Business (2015-2020)
  • 13.6.5 Celgene Recent Development
• 13.7 Basilea Pharmaceutica
  • 13.7.1 Basilea Pharmaceutica Company Details
  • 13.7.2 Basilea Pharmaceutica Business Overview and Its Total Revenue
  • 13.7.3 Basilea Pharmaceutica Skin Disease Treatment Introduction
  • 13.7.4 Basilea Pharmaceutica Revenue in Skin Disease Treatment Business (2015-2020)
  • 13.7.5 Basilea Pharmaceutica Recent Development
• 13.8 Cipher Pharmaceuticals
  • 13.8.1 Cipher Pharmaceuticals Company Details
  • 13.8.2 Cipher Pharmaceuticals Business Overview and Its Total Revenue
  • 13.8.3 Cipher Pharmaceuticals Skin Disease Treatment Introduction
  • 13.8.4 Cipher Pharmaceuticals Revenue in Skin Disease Treatment Business (2015-2020)
  • 13.8.5 Cipher Pharmaceuticals Recent Development
• 13.9 Agenus
  • 13.9.1 Agenus Company Details
  • 13.9.2 Agenus Business Overview and Its Total Revenue
  • 13.9.3 Agenus Skin Disease Treatment Introduction
  • 13.9.4 Agenus Revenue in Skin Disease Treatment Business (2015-2020)
  • 13.9.5 Agenus Recent Development
• 13.10 Astion Pharma A/S
  • 13.10.1 Astion Pharma A/S Company Details
  • 13.10.2 Astion Pharma A/S Business Overview and Its Total Revenue
  • 13.10.3 Astion Pharma A/S Skin Disease Treatment Introduction
  • 13.10.4 Astion Pharma A/S Revenue in Skin Disease Treatment Business (2015-2020)
  • 13.10.5 Astion Pharma A/S Recent Development
• 13.11 Bristol-Myers Squibb
  • 10.11.1 Bristol-Myers Squibb Company Details
  • 10.11.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  • 10.11.3 Bristol-Myers Squibb Skin Disease Treatment Introduction
  • 10.11.4 Bristol-Myers Squibb Revenue in Skin Disease Treatment Business (2015-2020)
  • 10.11.5 Bristol-Myers Squibb Recent Development
• 13.12 Almirall S.A.
  • 10.12.1 Almirall S.A. Company Details
  • 10.12.2 Almirall S.A. Business Overview and Its Total Revenue
  • 10.12.3 Almirall S.A. Skin Disease Treatment Introduction
  • 10.12.4 Almirall S.A. Revenue in Skin Disease Treatment Business (2015-2020)
  • 10.12.5 Almirall S.A. Recent Development
• 13.13 Galderma
  • 10.13.1 Galderma Company Details
  • 10.13.2 Galderma Business Overview and Its Total Revenue
  • 10.13.3 Galderma Skin Disease Treatment Introduction
  • 10.13.4 Galderma Revenue in Skin Disease Treatment Business (2015-2020)
  • 10.13.5 Galderma Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer